Middletown, DE -- (SBWIRE) -- 10/09/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: News Corp (NASDAQ:NWSA), Galena Biopharma Inc(NASDAQ:GALE), Idenix Pharmaceuticals Inc(NASDAQ:IDIX), Delcath Systems, Inc.(NASDAQ:DCTH)
News Corp (NASDAQ:NWSA) gained volume of 4.83 million shares and the average volume of the stock remained 6.55 million shares. The 52 week range of the stock remained $14.39 - $17.26 and the day range was $15.51 - $15.98.The stock opened the session at $15.51, and closed the session at $15.80. The stock showed a negative performance of -0.69% in previous trading session. News Corporation, a media and information services company, focuses on creating and distributing authoritative and engaging content to consumers and businesses worldwide. The company operates through five segments: News and Information Services, Cable Network Programming, Digital Real Estate Services, Book Publishing, and Other.
Has NWSA Found The Bottom and Ready To Move Up? Find Out Here
In previous session, Galena Biopharma Inc(NASDAQ:GALE) traded 4.78 million shares and the average volume of the stock remained 3.55 million shares. The 52 week range of the stock remained $1.23 - $3.00. The stock was a bear and dropped -4.48%, while its closing price stayed at $2.13. The market capitalization of the stock remained 179.84 million. The half-yearly trend of the stock remained positive +2.40%. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Has GALE Found The Bottom And Ready To Gain Momentum? Find Out Here
Idenix Pharmaceuticals Inc(NASDAQ:IDIX) volume of the stock was 4.72 million shares in the most recent session and the average volume remained 1.01 million shares. The stock plunged -16.18% and finished the prior session at the closing price of $3.99. The stock traded 4.72 million shares in its previous trading session and its average volume remained 1.01 million shares. Idenix Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and France. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV).
Why Should Investors Buy IDIX After the Recent Fall? Just Go Here and Find Out
Delcath Systems, Inc.(NASDAQ:DCTH) traded with volume of 4.64 million shares and the average volume of the stock remained 4.12 million shares. The stock decreased -9.28% and finished the trading at $0.440. The market capitalization of the stock remained 44.68 million. The beta of the stock remained 1.91. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology. The companys proprietary technology enables the administration of high-dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents.
Will DCTH Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)